{
  "ptid_time": "100_S_0190_2007-05-10",
  "img_path": "/data/qiuhui/data/adni/images/100_S_0190/2007-05-10/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 84,878 mm³, 120.4% above the reference mean. With a Z-score of 2.88 (99.8th percentile), this represents significant enlargement; hippocampal volume measures 4,638 mm³, 38.6% below the reference mean. With a Z-score of -3.77 (0.0th percentile), this represents profound atrophy; whole brain volume measures 953,792 mm³, 11.6% below the reference mean. With a Z-score of -1.51 (6.5th percentile), this represents moderate atrophy; entorhinal cortex volume measures 1,676 mm³, 59.1% below the reference mean. With a Z-score of -4.01 (0.0th percentile), this represents profound atrophy; fusiform gyrus volume measures 14,191 mm³, 24.7% below the reference mean. With a Z-score of -2.10 (1.8th percentile), this represents significant atrophy; middle temporal gyrus volume measures 14,561 mm³, 31.8% below the reference mean. With a Z-score of -2.86 (0.2th percentile), this represents significant atrophy. ",
  "text_data": "Age is 79.8 years. Gender is Male. Education: 18 years. MMSE: 25.0. Logical Memory: 3.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 827.20 pg/mL (normal ); Total tau: 339.60 pg/mL (mild elevated); Phosphorylated tau: 34.38 pg/mL (moderate elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows profound atrophy in the hippocampus and entorhinal cortex, along with significant ventricular enlargement and atrophy in other temporal lobe regions—all hallmarks of Alzheimer's neurodegeneration. Despite a normal Aβ (amyloid) level, the elevated T-tau and P-tau (markers of neuronal injury and tau pathology) and borderline MMSE score suggest a tau-driven neurodegenerative process, possibly atypical AD or primary age-related tauopathy (PART).  \n\n**Diagnosis:** **Dementia** (likely atypical Alzheimer's or mixed pathology)  \n**Confidence:** **Medium** (due to discordance between amyloid negativity and tau elevation, but structural atrophy strongly supports neurodegeneration)",
  "timestamp": "2025-07-26T11:17:28.038728"
}